Korea Bipolar Disorder Therapeutics Market Size By Type (Anticonvulsants, Mood Stabilizers), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), And Forecast

Korea Bipolar Disorder Therapeutics Market Size And Forecast

Korea Bipolar Disorder Therapeutics Market size was valued at USD 132.80 Million in 2023 and is projected to reach USD 211.68 Million by 2030, growing at a CAGR of 6.15% from 2024 to 2030.

Growing elderly population with higher risk of bipolar disorder and expansion of mental health services are the factors driving market growth. The Korea Bipolar Disorder Therapeutics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Korea Bipolar Disorder Therapeutics Market Definition

The Korea Bipolar Disorder Therapeutics Market refers to the industry focused on the diagnosis, treatment, and management of bipolar disorder within the Korean healthcare system. It encompasses various stakeholders, including pharmaceutical companies, healthcare providers, research organizations, and patients.

The market for bipolar disorder therapeutics in Korea is driven by the increasing prevalence of bipolar disorder, a mental health condition characterized by extreme mood swings, and associated healthcare needs. The introduction of pharmacological treatments, psychotherapy approaches, and psychosocial interventions form the foundation of the market, aiming to alleviate symptoms, stabilize mood, and improve the quality of life for individuals with bipolar disorder.

The increasing prevalence of bipolar disorder in Korea drives the demand for effective therapeutics to address the needs of affected individuals. Heightened awareness of mental health disorders, including bipolar disorder, among the general population, healthcare professionals, and policymakers contributes to increased diagnosis rates and treatment-seeking behavior. Ongoing research in the field of bipolar disorder facilitates the development of innovative treatments, personalized medicine approaches, and evidence-based interventions.

The integration of personalized medicine approaches, such as pharmacogenomics and biomarker research, enables tailored treatment strategies and improved patient outcomes. The focus on patient-centered approaches, including shared decision-making, psychosocial interventions, and holistic care, provides opportunities to enhance treatment effectiveness and patient satisfaction. The adoption of digital tools, such as mobile apps and wearable devices, for self-management, remote monitoring, and telepsychiatry services, offers opportunities to improve access, engagement, and convenience of bipolar disorder therapeutics.

Korea Bipolar Disorder Therapeutics Market Overview

Formerly known as manic depression, bipolar disorder is characterized by alternate periods of depression and abnormally elevated mood. Bipolar disorder is characterized by diverse symptoms including manic, hypomanic, depressive, mixed and psychotic features, and by chronically debilitating patterns that create challenges for treatment. Bipolar disorder treatment in South Korea has seen a sharp rise in number of patients. According to the data from the National Health Insurance Service, an average annual growth rate of 4.9 percent over the five-year period before COVID situation.

So, in 2019, looking at treatments paid for by the state's health insurance, we saw some interesting jumps. The biggest increase was in folks in their 70s and older, with a rise of about 12 to 14 percent! Twenty-somethings weren't far behind, seeing an 8 to 10 percent increase, and people in their 60s had a rise of around 7 to 9 percent. Now, if we rewind to 2017, the number of women getting treatment grew by about 4.6 percent each year, while for men, it was a bit higher at 5.2 percent. When it comes to bipolar disorder, estimates say it affects around 2 to 3 percent - or maybe even less than 0.2 percent - of South Koreans. That's even with more and more people seeking help for it.

Furthermore, advancement in the pharmaceutical industry in South Korea also benefits this industry. The pharmaceutical industry plays a crucial role in providing medications for the treatment of bipolar disorder. Companies may develop and manufacture mood stabilizers, antipsychotics, and other medications commonly prescribed to manage the symptoms of bipolar disorder. Increased investment in research and development has been a key trend. Both public and private sectors have been contributing to advancements in drug discovery, innovative therapies, and technology-driven solutions.

And hey, it's not just the meds themselves helping folks with bipolar disorder! The growing number of government programs focused on mental health is a big deal too. For example, just last December (2023), South Korea launched a really cool initiativemental health checkups every couple of years for young adults (20-34), plus custom counseling for everyone else. It's their first major policy push to tackle those sadly high suicide rates. We're talking 25.2 deaths per 100,000 people in 2022 – more than double the average for OECD countries (10.6 per 100,000). Sadly, that gives Korea the highest rate among OECD members, something they haven't seen in almost 20 years. The government's also planning to really step up after the checkups, working with hospital psych departments and mental health centers to make sure people get the ongoing support they need.

Korea Bipolar Disorder Therapeutics MarketSegmentation Analysis

The Korea Bipolar Disorder Therapeutics Market is segmented on the basis of Type and Distribution Channel.

Korea Bipolar Disorder Therapeutics Market, By Type

• Antipsychotics and Antidepressant
• Anticonvulsants
• Mood Stabilizers
• Others

To Get a Summarized Market Report By Type- 

Based on Type, The market is classified into Antipsychotics and Antidepressant, Anticonvulsants, Mood Stabilizers, and Others. Antipsychotics and Antidepressant accounted for the largest market share of 45.45% in 2022, with a market Value of USD 60.36 Million and is projected to grow at a CAGR of 6.30% during the forecast period.

Korea Bipolar Disorder Therapeutics Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

To Get a Summarized Market Report By Distribution Channel-

Based on Distribution Channel, The market is classified into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Hospital Pharmacies accounted for the largest market share of 45.22% in 2022, with a market Value of USD 60.05 Million and is projected to grow at a CAGR of 6.53% during the forecast period.

Key Players

The “Korea Bipolar Disorder Therapeutics Market” study report will provide a valuable insight with an emphasis on the market. The major players in the market are Janssen Pharmaceuticals, GlaxoSmithKline, AstraZeneca, Dong-A Pharmaceutical, Novartis AG, Lotus Pharmaceuticals, Wolters Kluwer, Luye Pharma Group, H. LUNDBECK A/S, and others.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Report Scope

To Get Customized Report Scope- 

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

We dive deep, using both numbers and broader trends, to break down the market into understandable segments based on economic realities and other important stuff. You'll get the scoop on market value (in USD Billion!) for each of these segments and sub-segments. We'll point out the region and segment we think will be the fastest growing and which will be the biggest overall. Plus, we'll analyze each region, highlighting how much of the product/service they use and the key factors impacting their market. Get the lowdown on the competition, including major players' market rankings, new launches, partnerships, expansions, and acquisitions from the last five years. We'll even give you detailed company profiles, with overviews, insights, product comparisons, and SWOT analyses. Expect a look at both the present and future of the market, considering recent events, growth opportunities, and the challenges in both new and mature regions. We also offer an in-depth look at the market from different angles using Porter's five forces and give you valuable insight through the value chain. Finally, we'll lay out the market's dynamics and future growth potential and you'll get 6-months of analyst support after the sale.

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.